TNF-alpha protects dendritic cells from prostate cancer-induced apoptosis. (Q53946508)

22 May 2018

title

TNF-alpha protects dendritic cells from prostate cancer-induced apoptosis. (English)

1 reference

22 May 2018

0 references

G Pirtskhalaishvili

1

1 reference

22 May 2018

G V Shurin

2

1 reference

22 May 2018

C Esche

3

1 reference

22 May 2018

D L Trump

4

1 reference

22 May 2018

M R Shurin

5

1 reference

22 May 2018

publication date

1 January 2001

1 reference

22 May 2018

Prostate Cancer and Prostatic Diseases

published in

1 reference

22 May 2018

volume

4

1 reference

22 May 2018

issue

4

1 reference

22 May 2018

page(s)

221-227

1 reference

22 May 2018

MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Dendritic cells presenting tumor antigen.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Synthesis and maturation of recombinant human tumor necrosis factor in eukaryotic systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

FLT3 ligand induces the generation of functionally active dendritic cells in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Distribution of Langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological grade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

TNF-induced signaling in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Influence of extracellular matrix proteins on the development of cultured human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500525

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500525

1 reference

22 May 2018

Dimensions Publication ID

1044826997

0 references

1 reference

22 May 2018